Australia’s Therapeutic Goods Administration issued guidance Thursday summarizing its annual drug and device fees and charges that will go into effect July 1, 2020. “The TGA is required to recover its costs for all activities that fall within the scope of the Therapeutic Goods Act 1989, including the TGA's public health responsibilities,” the guidance said. The fees laid out in the guidance cover services, such as a product evaluation, whereas a charge is a form of tax that’s applied annually based on a July 1 to a June 30 fiscal year.

No Comments